AiXin Life International, Inc. (AIXN)
OTCMKTS: AIXN · Delayed Price · USD
0.653
+0.373 (133.21%)
Jul 23, 2024, 4:00 PM EDT - Market closed

Company Description

AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China.

The company operates through four segments: Products, Pharmacies, Hotel, and Manufacture and Sales. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, foods, and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules.

The company provides products purchased from third parties, as well as advertising and marketing services.

It sells its products through its pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing, as well, as an omni-channel business.

The company is based in Chengdu, China.

AiXin Life International, Inc.
Country United States
Founded 1987
Industry Food Distribution
Sector Consumer Staples
Employees 207
CEO Quanzhong Lin

Contact Details

Address:
Hongxing Intl Business Building 2, 14th Flr, No. 69, Qingyun Souve Ave.,
Jinjiang District,chengdu City, F4 610021
China
Phone 212-739-7689
Website aixinjituan.com

Stock Details

Ticker Symbol AIXN
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000835662
CUSIP Number 009603200
ISIN Number US0096033099
Employer ID 84-1085935
SIC Code 5912

Key Executives

Name Position
Quanzhong Lin Secretary, President, Chief Executive Officer and Chairman
Tianfeng Li Chief Financial Officer and Treasurer

Latest SEC Filings

Date Type Title
Jun 13, 2024 10-Q Quarterly Report
May 16, 2024 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Apr 8, 2024 10-K Annual Report
Apr 2, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Feb 9, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 14, 2023 10-Q Quarterly Report
Aug 18, 2023 10-Q Quarterly Report
Aug 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Jul 25, 2023 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jun 26, 2023 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933